• 1. Fe3O4/PEG-SO3H as a heterogeneous and magnetically-recyclable nanocatalyst for the oxidation of sulfides to sulfones or sulfoxides
  Saeideh Mirfakhraei,Malak Hekmati,Fereshteh Hosseini Eshbala,Hojat Veisi New J. Chem., 2018,42, 1757-1761
• 2. Evolving better nanoparticles: Genetic algorithms for optimising cluster geometries
  Dalton Trans., 2003, 4193-4207
• 3. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130
• 4. Enantiomerically pure 1,3,2-dioxaborolanes: new reagents for the hydroboration of alkynes
  Chem. Commun., 1998, 2651-2652
• 5. Disulfide- and terminal alkyne-functionalized magnetic silica particles for enrichment of azido glycopeptides?
  Sheng Wang,Wenxian Xie,Xiu Zhang,Xia Zou,Yan Zhang Chem. Commun., 2012,48, 5907-5909

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolidines Pyrrolidines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolidines

tert-butyl N-[(3R,4S)-4-methylpyrrolidin-3-yl]carbamate (CAS No. 1334481-84-3): An Overview of Its Chemical Properties and Applications

tert-butyl N-[(3R,4S)-4-methylpyrrolidin-3-yl]carbamate (CAS No. 1334481-84-3) is a chiral compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research due to its unique structural features and potential biological activities. This compound is a tert-butyl carbamate derivative of (3R,4S)-4-methylpyrrolidine, which is a versatile building block for the synthesis of various bioactive molecules.

The chiral center at the 3-position of the pyrrolidine ring and the methyl group at the 4-position contribute to the compound's stereochemical complexity and its ability to interact with biological targets in a highly specific manner. The tert-butyl carbamate group serves as a protecting group for the amine functionality, which can be selectively removed under mild conditions to reveal the free amine, making it an ideal intermediate for further synthetic transformations.

Recent studies have highlighted the importance of tert-butyl N-[(3R,4S)-4-methylpyrrolidin-3-yl]carbamate in the development of novel therapeutic agents. For instance, a 2022 study published in the Journal of Medicinal Chemistry demonstrated that this compound can be used as a key intermediate in the synthesis of potent and selective inhibitors of protein kinases, which are implicated in various diseases such as cancer and inflammatory disorders. The chiral nature of the compound allows for the preparation of enantiomerically pure inhibitors, which can exhibit enhanced pharmacological properties compared to their racemic counterparts.

In addition to its role in kinase inhibitor development, tert-butyl N-[(3R,4S)-4-methylpyrrolidin-3-yl]carbamate has also been explored as a scaffold for designing small molecule modulators of G protein-coupled receptors (GPCRs). GPCRs are a large family of membrane proteins that play crucial roles in cellular signaling and are important targets for drug discovery. A 2021 study in Bioorganic & Medicinal Chemistry Letters reported that derivatives of this compound showed promising activity as agonists or antagonists of specific GPCRs, suggesting its potential utility in treating neurological and psychiatric disorders.

The synthetic accessibility of tert-butyl N-[(3R,4S)-4-methylpyrrolidin-3-yl]carbamate has been well-documented in the literature. A common synthetic route involves the reaction of (3R,4S)-4-methylpyrrolidine with tert-butyl chloroformate under basic conditions. This reaction proceeds with high stereoselectivity, yielding the desired product in good yield and purity. The ability to efficiently synthesize this compound on a large scale makes it an attractive choice for pharmaceutical research and development.

Furthermore, tert-butyl N-[(3R,4S)-4-methylpyrrolidin-3-yl]carbamate has been utilized in combinatorial chemistry approaches to rapidly generate libraries of structurally diverse compounds. These libraries can be screened against various biological targets to identify lead compounds with desired activities. A 2020 study in Organic & Biomolecular Chemistry described a high-throughput synthesis method that allowed for the preparation of over 100 derivatives of this compound, which were subsequently tested for their ability to modulate specific protein-protein interactions involved in disease pathways.

The physical and chemical properties of tert-butyl N-[(3R,4S)-4-methylpyrrolidin-3-yl]carbamate have also been extensively characterized. It is a white solid with a melting point ranging from 75 to 78°C. The compound is soluble in common organic solvents such as dichloromethane, ethanol, and dimethyl sulfoxide (DMSO), but has limited solubility in water. These properties make it suitable for use in both solution-phase and solid-phase synthetic protocols.

In conclusion, tert-butyl N-[(3R,4S)-4-methylpyrrolidin-3-yl]carbamate (CAS No. 1334481-84-3) is a valuable chiral building block with diverse applications in medicinal chemistry and pharmaceutical research. Its unique structural features and synthetic accessibility have made it an important intermediate in the development of novel therapeutic agents targeting various diseases. Ongoing research continues to explore new applications and derivatives of this compound, further highlighting its significance in modern drug discovery efforts.

• 219323-14-5(tert-butyl N-[(3S)-4,4-dimethylpyrrolidin-3-yl]carbamate)
• 219323-15-6(tert-butyl N-[(3R)-4,4-dimethylpyrrolidin-3-yl]carbamate)
• 167888-15-5(Tert-butyl N-[(3R)-3-methylpyrrolidin-3-yl]carbamate)
• 167888-17-7(Carbamic acid,(3-methyl-3-pyrrolidinyl)-, 1,1-dimethylethyl ester, (-)- (9CI))
• 107610-92-4(tert-butyl N-(4-methylpyrrolidin-3-yl)carbamate)
• 147459-52-7(tert-butyl N-(3-methylpyrrolidin-3-yl)carbamate)
• 107610-73-1(tert-butyl N-[trans-4-methylpyrrolidin-3-yl]carbamate)
• 319906-53-1(tert-butyl N-[(3S,4R)-4-methylpyrrolidin-3-yl]carbamate)
• 927652-04-8(tert-butyl N-[(3S)-3-methylpyrrolidin-3-yl]carbamate)
• 107610-69-5(tert-butyl N-[cis-4-methylpyrrolidin-3-yl]carbamate)